Evidence map›Paper›PMID 37444722›Full record

ArticleHealthcare (Basel, Switzerland)2023

Neurosensory Affectation in Patients Affected by Wolfram Syndrome: Descriptive and Longitudinal Analysis.

Gema Esteban-Bueno, Aída María Berenguel Hernández, Nicolás Fernández Fernández, Miguel Navarro Cabrero, Juan R Coca

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gema Esteban-BuenoClinical Management Unit Almería Periphery-Almería Health District, Andalusian Health Service, 04120 Costacabana, Almería, Spain.ORCID 0000-0001-7554-9434
Aída María Berenguel HernándezClinical Genetics Biogenox, 04720 Aguadulce, Almería, Spain.ORCID 0000-0002-3600-3604
Nicolás Fernández FernándezLa Inmaculada Hospital, Andalusian Health Service, 04600 Huércal-Overa, Almeria, Spain.ORCID 0000-0001-9727-4179
Miguel Navarro CabreroSpanish Association for the Research and Support of Wolfram Syndrome, 04120 Costacabana, Almería, Spain.ORCID 0000-0003-4850-178X
Juan R CocaSocial Research Unit on Health and Rare Diseases, Department of Sociology and Social Work, University of Valladolid, 42004 Soria, Castile and León, Spain.ORCID 0000-0003-1140-7351
Andalusian Health Service · ESUniversidad de Valladolid · ES

Funding

Evaluation of the effectiveness of a biopsychosocial intervention plan applied through ICTs to improve the quality of life of people affected by rare diseases. Funded by the Andalusian Public Health System (Conv. FPS 2020) AP-0009-2020-C1-F2
6 · The paper itself

Abstract

Wolfram syndrome (WS) is a rare neurodegenerative disease usually of autosomal recessive origin. There is limited research about sensorineural hearing loss, despite it being a fundamental entity. It is important to broaden the study of this disease and specify a set of tests required for an adequate assessment of patients for efficient monitoring and control. The fundamental objective of this research is to understand WS from a biomedical perspective in order to help in its diagnosis, follow-up, and control. Pure tones audiometry, tympanometry, speech perception, the speech intelligibility index without aid, and testing at high frequencies were among the audiological measurements utilised since they were deemed suitable for standardised follow-up. Mixed linear models were used to examine the effects of age, time, or mean interaction in pure-tone (IPT), the average of high frequencies (HFA), auditory brainstem response (ABR), and brainstem auditory evoked potentials (BAEP). The genetic analysis allowed mutations to be classified into three phenotype-genotype groups, where the phenotype indicated the severity of the hearing loss. Patients with homozygous gene changes had a more severe neurosensory phenotype. The early discovery of sensorineural hearing loss and WS is crucial since it allows intensive follow-up and treatment of the person affected from the start.

Indexed as

DIDMOADgenetic mutationhearing impairmenthearing lossWolfram syndrome

Identifiers

PMID37444722
PMCPMC10340328
OpenAlexW4382864961

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.